Riest 2008.
Study characteristics | ||
Methods | Study design: parallel‐group randomized controlled trial Sample size: 160 Country: Germany Setting: secondary care hospital Dates conducted: not reported Postoperative opioid used and delivery: morphine PCA Pain score collection: trained nurse Concurrent postoperative analgesics: none reported | |
Participants |
Inclusion criteria
Exclusion criteria
|
|
Interventions |
Group Perioperative (80 participants): 40 mg IV parecoxib 45 minutes before surgery and 12 and 24 hours after surgery Group Postoperative (80 participants): placebo 45 minutes before surgery and 12 and 24 hours after surgery |
|
Outcomes |
|
|
Notes | Funding: "Investigator initiated trial funded by Pfizer, Germany. Pfizer did not participate in generation of the study design or interpretation of results". Declarations of interest: as above Authors contacted: no Other: unable to include opioid adverse events as not individually reported. Pain not included as average used |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Computer‐generated. Quote: "...randomization with a computer‐generated random list" |
Allocation concealment (selection bias) | Unclear risk | No mention |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Double‐dummy placebo used |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No mention |
Incomplete outcome data (attrition bias) All outcomes | High risk | Many patients excluded but unclear to which groups they belonged. Quote: "43 patients were excluded before assessment of the primary criteria for the following reasons..." |
Selective reporting (reporting bias) | Unclear risk | No protocol or trial registration |
Other bias | Unclear risk | No baseline characteristics table. Industry funded but stated no involvement in study |